Here are five things to know:
1. Total revenue for the quarter was $23 million, a 3 percent increase compared to the second quarter of 2018.
2. U.S. commercial revenue grew 3 percent compared to the second quarter of 2018, totalling$21 million.
3. Alphatec’s total operating expenses for the quarter were $22.4 million compared to $20.8 million in the second quarter of 2018.
4. As of Sept. 30, Alphatec had $35.1 million in cash and cash equivalents on hand compared to $44.9 million June 30.
5. By the end of the year, Alphatec expects total revenue to range between $92 million and $95 million. The company expects fourth quarter revenue to grow 10 percent.
To read the full report, click here.
More articles on devices and implants:
Everything to know about Stryker & K2M $1.4B deal
Spine implant manufacturer gets makeover with new headquarters
DJO makes new partnership: 3 details
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
